Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial

Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, indicating an access restriction. This suggests a server-side issue or blocked access to the study record page.
    Difference
    17%
    Check dated 2026-09-20T20:26:12.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Locations list now includes Tel Litwinsky, Israel, 52621 as a new site and removes Qiryat Krinitzi, Israel, 52621 from the study locations.
    Difference
    0.1%
    Check dated 2026-09-13T21:40:35.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Qiryat Krinitzi, Israel, 52621 was added as a study site and Tel Litwinsky, Israel, 52621 was removed, altering the geographic footprint of trial locations and potentially where participants can enroll.
    Difference
    0.1%
    Check dated 2026-09-06T18:14:58.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    A new site revision label, Revision: v3.6.6, was added to the page, replacing the previous Revision: v3.6.5, indicating a deployed update.
    Difference
    0.0%
    Check dated 2026-08-30T15:29:28.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    A new publication citation for Tolebrutinib liver safety was added and the page revision updated to v3.6.5. The plain language results summary, sponsor label, and Helpful Links section were removed as part of a UI/content cleanup.
    Difference
    0.1%
    Check dated 2026-08-09T09:10:56.000Z thumbnail image

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.